Literature DB >> 33914116

Glioma grading, molecular feature classification, and microstructural characterization using MR diffusional variance decomposition (DIVIDE) imaging.

Sirui Li1, Yuan Zheng2, Wenbo Sun1, Samo Lasič3, Filip Szczepankiewicz3,4, Qing Wei5, Shihong Han5, Shuheng Zhang5, Xiaoli Zhong1, Liang Wang1, Huan Li1, Yuxiang Cai1, Dan Xu1, Zhiqiang Li1, Qiang He5, Danielle van Westen4, Karin Bryskhe3, Daniel Topgaard5, Haibo Xu6.   

Abstract

OBJECTIVE: To evaluate the potential of diffusional variance decomposition (DIVIDE) for grading, molecular feature classification, and microstructural characterization of gliomas.
MATERIALS AND METHODS: Participants with suspected gliomas underwent DIVIDE imaging, yielding parameter maps of fractional anisotropy (FA), mean diffusivity (MD), anisotropic mean kurtosis (MKA), isotropic mean kurtosis (MKI), total mean kurtosis (MKT), MKA/MKT, and microscopic fractional anisotropy (μFA). Tumor type and grade, isocitrate dehydrogenase (IDH) 1/2 mutant status, and the Ki-67 labeling index (Ki-67 LI) were determined after surgery. Statistical analysis included 33 high-grade gliomas (HGG) and 17 low-grade gliomas (LGG). Tumor diffusion metrics were compared between HGG and LGG, among grades, and between wild and mutated IDH types using appropriate tests according to normality assessment results. Receiver operating characteristic and Spearman correlation analysis were also used for statistical evaluations.
RESULTS: FA, MD, MKA, MKI, MKT, μFA, and MKA/MKT differed between HGG and LGG (FA: p = 0.047; MD: p = 0.037, others p < 0.001), and among glioma grade II, III, and IV (FA: p = 0.048; MD: p = 0.038, others p < 0.001). All diffusion metrics differed between wild-type and mutated IDH tumors (MKI: p = 0.003; others: p < 0.001). The metrics that best discriminated between HGG and LGGs and between wild-type and mutated IDH tumors were MKT and FA respectively (area under the curve 0.866 and 0.881). All diffusion metrics except FA showed significant correlation with Ki-67 LI, and MKI had the highest correlation coefficient (rs = 0.618).
CONCLUSION: DIVIDE is a promising technique for glioma characterization and diagnosis. KEY POINTS: • DIVIDE metrics MKI is related to cell density heterogeneity while MKA and μFA are related to cell eccentricity. • DIVIDE metrics can effectively differentiate LGG from HGG and IDH mutation from wild-type tumor, and showed significant correlation with the Ki-67 labeling index. • MKI was larger than MKA which indicates predominant cell density heterogeneity in gliomas. • MKA and MKI increased with grade or degree of malignancy, however with a relatively larger increase in the cell eccentricity metric MKA in relation to the cell density heterogeneity metric MKI.

Entities:  

Keywords:  Classification; Diffusion magnetic resonance imaging; Glioma; Isocitrate dehydrogenase; Neuroimaging

Year:  2021        PMID: 33914116     DOI: 10.1007/s00330-021-07959-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  27 in total

1.  Gene expression profiling of gliomas strongly predicts survival.

Authors:  William A Freije; F Edmundo Castro-Vargas; Zixing Fang; Steve Horvath; Timothy Cloughesy; Linda M Liau; Paul S Mischel; Stanley F Nelson
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

2.  Multidimensional diffusion MRI.

Authors:  Daniel Topgaard
Journal:  J Magn Reson       Date:  2016-12-19       Impact factor: 2.229

3.  Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status.

Authors:  Jing Zhao; Yu-Liang Wang; Xin-Bei Li; Man-Shi Hu; Zhu-Hao Li; Yu-Kun Song; Jing-Yan Wang; Yi-Su Tian; Da-Wei Liu; Xu Yan; Li Jiang; Zhi-Yun Yang; Jian-Ping Chu
Journal:  J Neurooncol       Date:  2018-11-09       Impact factor: 4.130

4.  Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.

Authors:  Christian Hartmann; Bettina Hentschel; Wolfgang Wick; David Capper; Jörg Felsberg; Matthias Simon; Manfred Westphal; Gabriele Schackert; Richard Meyermann; Torsten Pietsch; Guido Reifenberger; Michael Weller; Markus Loeffler; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2010-11-19       Impact factor: 17.088

5.  The link between diffusion MRI and tumor heterogeneity: Mapping cell eccentricity and density by diffusional variance decomposition (DIVIDE).

Authors:  Filip Szczepankiewicz; Danielle van Westen; Elisabet Englund; Carl-Fredrik Westin; Freddy Ståhlberg; Jimmy Lätt; Pia C Sundgren; Markus Nilsson
Journal:  Neuroimage       Date:  2016-07-20       Impact factor: 6.556

6.  In vivo molecular profiling of human glioma using diffusion kurtosis imaging.

Authors:  Johann-Martin Hempel; Sotirios Bisdas; Jens Schittenhelm; Cornelia Brendle; Benjamin Bender; Henk Wassmann; Marco Skardelly; Ghazaleh Tabatabai; Salvador Castaneda Vega; Ulrike Ernemann; Uwe Klose
Journal:  J Neurooncol       Date:  2016-09-07       Impact factor: 4.130

Review 7.  Isocitrate dehydrogenase mutations in gliomas.

Authors:  Matthew S Waitkus; Bill H Diplas; Hai Yan
Journal:  Neuro Oncol       Date:  2015-07-16       Impact factor: 13.029

8.  Clinical and Pathologic Features and Prognostic Factors for Recurrent Gliomas.

Authors:  Jiaoming Li; Xiaodong Niu; Youjun Gan; Yuan Yang; Tianwei Wang; Haodongfang Zhang; Yanhui Liu; Qing Mao
Journal:  World Neurosurg       Date:  2019-03-14       Impact factor: 2.210

9.  Tensor-valued diffusion MRI in under 3 minutes: an initial survey of microscopic anisotropy and tissue heterogeneity in intracranial tumors.

Authors:  Markus Nilsson; Filip Szczepankiewicz; Jan Brabec; Marie Taylor; Carl-Fredrik Westin; Alexandra Golby; Danielle van Westen; Pia C Sundgren
Journal:  Magn Reson Med       Date:  2019-09-13       Impact factor: 4.668

10.  Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation.

Authors:  Rifeng Jiang; Jingjing Jiang; Lingyun Zhao; Jiaxuan Zhang; Shun Zhang; Yihao Yao; Shiqi Yang; Jingjing Shi; Nanxi Shen; Changliang Su; Ju Zhang; Wenzhen Zhu
Journal:  Oncotarget       Date:  2015-12-08
View more
  3 in total

1.  Clinical experience of tensor-valued diffusion encoding for microstructure imaging by diffusional variance decomposition in patients with breast cancer.

Authors:  Eun Cho; Hye Jin Baek; Filip Szczepankiewicz; Hyo Jung An; Eun Jung Jung; Ho-Joon Lee; Joonsung Lee; Sung-Min Gho
Journal:  Quant Imaging Med Surg       Date:  2022-03

2.  Separating Glioma Hyperintensities From White Matter by Diffusion-Weighted Imaging With Spherical Tensor Encoding.

Authors:  Jan Brabec; Faris Durmo; Filip Szczepankiewicz; Patrik Brynolfsson; Björn Lampinen; Anna Rydelius; Linda Knutsson; Carl-Fredrik Westin; Pia C Sundgren; Markus Nilsson
Journal:  Front Neurosci       Date:  2022-04-21       Impact factor: 5.152

3.  MR Fingerprinting with b-Tensor Encoding for Simultaneous Quantification of Relaxation and Diffusion in a Single Scan.

Authors:  Maryam Afzali; Lars Mueller; Ken Sakaie; Siyuan Hu; Yong Chen; Filip Szczepankiewicz; Mark A Griswold; Derek K Jones; Dan Ma
Journal:  Magn Reson Med       Date:  2022-06-17       Impact factor: 3.737

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.